BACKGROUND: Most available studies on the psychiatric, neuropsychological, and neurological complications of HIV-1 infection and AIDS have been conducted in Western countries, on samples of well-educated, mostly white, homosexual men. Concerns about generalizability of the results of those investigations prompted the WHO to implement the cross-cultural venture called WHO Neuropsychiatric AIDS study. METHODS: This project aims to assess the prevalence and natural history of HIV-1-associated psychiatric, neuropsychological, and neurological abnormalities in representative subject samples enrolled in the five geographic areas predominantly affected by the HIV-1 epidemic. Assessment is made by a data collection instrument including six modules. The intercenter and intracenter reliability in the use of each module has been formally evaluated. The study consists of a cross-sectional phase and a longitudinal follow-up. RESULTS: The cross-sectional phase was completed in five centers. This paper reports on the results of psychiatric assessment, which revealed a significantly higher prevalence of current mental disorders in symptomatic seropositive persons compared with seronegative controls among intravenous drug users in Bangkok and homosexuals/bisexuals in São Paulo. The mean global score on the Montgomery-Asberg Depression Rating Scale was significantly higher in symptomatic seropositive individuals than in matched seronegative controls in all centers. CONCLUSIONS: These results suggest that the significance of the psychopathological complications of symptomatic HIV-1 infection may have been underestimated by previous studies conducted on self-selected samples of well-educated, middle-class, mostly white, homosexual men.
BACKGROUND: Most available studies on the psychiatric, neuropsychological, and neurological complications of HIV-1 infection and AIDS have been conducted in Western countries, on samples of well-educated, mostly white, homosexual men. Concerns about generalizability of the results of those investigations prompted the WHO to implement the cross-cultural venture called WHO Neuropsychiatric AIDS study. METHODS: This project aims to assess the prevalence and natural history of HIV-1-associated psychiatric, neuropsychological, and neurological abnormalities in representative subject samples enrolled in the five geographic areas predominantly affected by the HIV-1 epidemic. Assessment is made by a data collection instrument including six modules. The intercenter and intracenter reliability in the use of each module has been formally evaluated. The study consists of a cross-sectional phase and a longitudinal follow-up. RESULTS: The cross-sectional phase was completed in five centers. This paper reports on the results of psychiatric assessment, which revealed a significantly higher prevalence of current mental disorders in symptomatic seropositive persons compared with seronegative controls among intravenous drug users in Bangkok and homosexuals/bisexuals in São Paulo. The mean global score on the Montgomery-Asberg Depression Rating Scale was significantly higher in symptomatic seropositive individuals than in matched seronegative controls in all centers. CONCLUSIONS: These results suggest that the significance of the psychopathological complications of symptomatic HIV-1 infection may have been underestimated by previous studies conducted on self-selected samples of well-educated, middle-class, mostly white, homosexual men.
Authors: Jane M Simoni; Steven A Safren; Lisa E Manhart; Karen Lyda; Cynthia I Grossman; Deepa Rao; Matthew J Mimiaga; Frank Y Wong; Sheryl L Catz; Michael B Blank; Ralph DiClemente; Ira B Wilson Journal: AIDS Behav Date: 2011-02
Authors: Robert K Heaton; Lucette A Cysique; Hua Jin; Chuan Shi; Xin Yu; Scott Letendre; Donald R Franklin; Christopher Ake; Ofilio Vigil; J Hampton Atkinson; Thomas D Marcotte; Igor Grant; Zunyou Wu Journal: J Neurovirol Date: 2008-11 Impact factor: 2.643
Authors: Brian W Pence; Bradley N Gaynes; Julius Atashili; Julie K O'Donnell; Gladys Tayong; Dmitry Kats; Rachel Whetten; Kathryn Whetten; Alfred K Njamnshi; Peter M Ndumbe Journal: J Affect Disord Date: 2012-07-27 Impact factor: 4.839
Authors: Rujvi Kamat; Erin Morgan; Thomas D Marcotte; Jayraan Badiee; Ingrid Maich; Mariana Cherner; Sergio de Almeida; Ana Paula de Pereira; Clea Elisa Ribeiro; Francisco Barbosa; J Hamp Atkinson; Ronald Ellis Journal: J Affect Disord Date: 2012-12-11 Impact factor: 4.839
Authors: V G Valcour; B T Shiramizu; P Sithinamsuwan; S Nidhinandana; S Ratto-Kim; J Ananworanich; U Siangphoe; J H Kim; M de Souza; V Degruttola; R H Paul; C M Shikuma Journal: Neurology Date: 2009-03-17 Impact factor: 9.910
Authors: Thep Chalermchai; Victor Valcour; Pasiri Sithinamsuwan; Suteeraporn Pinyakorn; David Clifford; Robert H Paul; Somporn Tipsuk; James L K Fletcher; Victor Degruttola; Silvia Ratto-Kim; Nicholas Hutchings; Cecilia Shikuma; Jintanat Ananworanich Journal: J Neurovirol Date: 2013-03-13 Impact factor: 2.643